SKK Holdings trims stock sale program to $25,000

SKK Holdings Limited is amending its at-the-market equity program for its Class A ordinary shares.

Rhea-AI Filing Summary

SKK Holdings Limited is amending its at-the-market equity program for its Class A ordinary shares. The company originally registered up to $5,540,009 of shares under a sales agreement with A.G.P./Alliance Global Partners. As of this supplement, $201,983.46 of shares have been sold under the agreement.

Effective July 31, 2026, the company is reducing the remaining aggregate offering price that may be offered and sold under the Sales Agreement to $25,000. The Sales Agreement otherwise remains in force. The offering will end when shares with an aggregate price of $25,000 are sold or the Sales Agreement is terminated. SKK’s Class A ordinary shares trade on Nasdaq under the symbol SKK, with a last reported sale price of $4.65 on July 30, 2026.

Filing Explained

The July 31, 2026 supplement stops sales under the May 18 prior supplement; the Sales Agreement remains active for up to $25,000 of Class A shares, but sales above that amount require a new prospectus supplement.

Key Figures

Original ATM capacity: $5,540,009 Amount already sold: $201,983.46 Revised remaining capacity: $25,000 +1 more

4 metrics

Original ATM capacity $5,540,009 Aggregate offering price of Class A ordinary shares registered under the Sales Agreement

Amount already sold $201,983.46 Class A ordinary shares sold under the Sales Agreement as of this supplement

Revised remaining capacity $25,000 New aggregate offering price limit for additional shares under the Sales Agreement

Last reported share price $4.65 Class A ordinary share price on Nasdaq on July 30, 2026

Key Terms

prospectus supplement, Sales Agreement, aggregate offering price, Nasdaq

4 terms

prospectus supplement regulatory

"This prospectus supplement supplements, modifies and supersedes..."

A prospectus supplement is an additional document provided alongside a company's main offering details, offering updated or extra information about a specific financial product being sold. It helps investors understand the latest terms, risks, and details of the investment, similar to how an update or revision clarifies or expands on original instructions, ensuring they have current and complete information before making a decision.

Sales Agreement regulatory

"pursuant to the terms of the sales agreement originally dated..."

A sales agreement is a written contract that sets out the terms for selling goods, services, or assets, specifying price, delivery, payment schedule and responsibilities of each side. For investors it matters because it creates a predictable stream of revenue or cash obligations, clarifies timing and risk, and can change a company’s value or forecasts much like a signed order turns a customer’s verbal intent into a firm commitment.

aggregate offering price financial

"to reduce the aggregate offering price of the Class A ordinary shares..."

The aggregate offering price is the total dollar amount that will be raised if all the securities in an offering are sold at the stated offering price, before fees or expenses are taken out. Investors use it to gauge the size of the fundraising and its potential effects—such as how much cash the company will get and how much existing ownership might be reduced—similar to totaling every item’s price in a shopping cart to see the full bill.

Nasdaq market

"Our Class A ordinary shares are listed on Nasdaq under the symbol..."

The Nasdaq is a stock exchange where many companies' shares are bought and sold, functioning much like a marketplace for investments. It matters to investors because it provides a platform to buy and sell ownership stakes in companies, helping them track the value of those companies and make informed decisions. As one of the largest and most technology-focused markets, it also reflects trends and developments in the business world.

Offering Details

ATM

Offering

Offering Type ATM

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What change to the at-the-market offering did SKK (SKK) make in this supplement?

SKK Holdings Limited reduced the remaining aggregate offering size under its at-the-market Sales Agreement to $25,000, while leaving all other terms of the Sales Agreement in effect.

How much of the original SKK (SKK) ATM program has already been sold?

Under the Sales Agreement, SKK has already sold $201,983.46 of its Class A ordinary shares out of the previously registered $5,540,009 aggregate offering amount.

What is the current maximum amount SKK (SKK) can sell under the Sales Agreement?

After this amendment, SKK may sell additional Class A ordinary shares having an aggregate offering price of up to $25,000 under the existing Sales Agreement with A.G.P.

When will SKK’s (SKK) at-the-market offering under this supplement terminate?

The offering will terminate upon the earlier of selling all shares with an aggregate offering price up to $25,000 or termination of the Sales Agreement by SKK or A.G.P. as permitted.

What was the last reported trading price of SKK (SKK) Class A shares?

On July 30, 2026, SKK’s Class A ordinary shares had a last reported sale price of $4.65 per share on the Nasdaq market.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 07/31/2026 - 05:30 PM Accepted by SEC EDGAR 07/31/2026 - 05:30 PM Learn about SEC filing dates

Amendment No. 1 dated July 31, 2026 To Prospectus Supplement dated May 15, 2026 Filed pursuant to Rule 424(b)(5) Registration No. 333-295547

Up to $25,000

Class A Ordinary Shares

SKK Holdings Limited

This prospectus supplement supplements, modifies and supersedes, only to the extent indicated herein, certain information contained in the prospectus dated May 15, 2026 (the “Base Prospectus”), as supplemented by the prospectus supplement dated May 18, 2026 (the “Prior Prospectus Supplement”) which, together with the Base Prospectus, is referred to here as the “Prospectus”), relating to the offering, issuance and sale of up to $5,540,009 of our Class A ordinary shares, par value of $0.0025 per share from time to time through our sales agent, A.G.P./Alliance Global Partners (“A.G.P.” or the “Sales Agent”), pursuant to the terms of the sales agreement originally dated May 18, 2026 (the “Sales Agreement”) between SKK Holdings Limited (the “Company” or “we” or “our” or “us”) and the Sales Agent.

Our Class A ordinary shares are listed on Nasdaq under the symbol “SKK.” On July 30, 2026, the last reported sale price of our Class A ordinary shares was $4.65 per Class A ordinary share. Under the Prospectus, we registered for offer and sale of up to $5,540,009 of our Class A ordinary shares pursuant to the Sales Agreement. As of the date of this prospectus supplement, $201,983.46 of our Class A ordinary shares have been sold pursuant to or under the Sales Agreement.

We are filing this prospectus supplement, as of July 31, 2026, to reduce the aggregate offering price of the Class A ordinary shares that may be offered and sold under the Sales Agreement and the Prior Prospectus Supplement to $25,000. This prospectus supplement does not affect any other terms of the Sales Agreement, which remains in full force and effect in accordance with its terms, except as described herein. This offering will terminate upon the earlier of (i) the sale of all shares of common stock subject to the Sales Agreement having an aggregate offering price of up to $25,000, or (ii) the termination of the Sales Agreement by us or the Agent as permitted therein.

No further shares will be sold pursuant to the Prior Prospectus Supplement following the date of this prospectus supplement. We will not make any sales of our Class A ordinary shares pursuant to the Sales Agreement in excess of $25,000 unless and until a new prospectus supplement is filed with the Securities and Exchange Commission and the Sales Agreement remains in full force and effect.

This prospectus supplement should be read in conjunction with, is not complete without, and may not be delivered or utilized except in connection with, the Prospectus, including all supplements thereto and documents incorporated by reference therein. If there is any inconsistency between the information in the Prospectus and this prospectus supplement, you should rely on the information in this prospectus supplement. Any information that is modified or superseded in the Prospectus shall not be deemed to constitute a part of the Prospectus, except as modified or superseded by this prospectus supplement.

Investing in our securities involves a high degree of risk. You should carefully review the risks and uncertainties described under the heading “Risk Factors” beginning on page S-4 of this prospectus supplement, the accompanying prospectus and under similar headings in the other documents that are incorporated by reference into this prospectus supplement and accompanying prospectus.

Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or passed upon the adequacy or accuracy of this prospectus supplement or the accompanying prospectus. Any representation to the contrary is a criminal offense.

Sole Sales Agent

A.G.P.

The date of this amendment No. 1 to the prospectus supplement is July 31, 2026.